Evaluation Of A Treatment Scheme With The Recombinant Grass Pollen Allergy Vaccine Bm32 Yielding High Allergen-Specific Igg Responses Associated With Clinical Efficacy P. U. Zieglmayer,M. Focke-Tejkl,M. Weber,R. Schmutz,P. Lemell, R. Zieglmayer,F. Stolz,H. Huber,A. Neubauer,F. Horak,R. Henning, R. ValentaALLERGY(2018)引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要